About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
April 17, 2015
click here to read more
Post navigation
Previous Post
Phosphagenics Appoints Three New Directors
Next Post
Appendix 3X Notices – Three New Directors
Related Posts
CEO Quarterly Update
October 4, 2017
2018 AGM Results
May 28, 2018
Phosphagenics Director and Founder Steps Down
July 9, 2015